New Zealand markets closed

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6344-0.0457 (-6.72%)
At close: 04:00PM EDT
0.6349 +0.00 (+0.08%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,327
5,822
5,992
7,811
9,559
Cost of revenue
1,652
1,631
2,289
1,600
4,046
Gross profit
2,675
4,191
3,703
6,212
5,513
Operating expenses
Research development
2,551
2,409
1,740
1,788
459.636
Selling general and administrative
13,467
9,261
12,209
15,593
15,675
Total operating expenses
22,393
14,954
19,548
24,260
22,795
Operating income or loss
-19,718
-10,762
-15,846
-18,048
-17,282
Interest expense
462.862
536.138
596.018
368.66
3,051
Total other income/expenses net
-3,820
2,620
-3,610
9,430
-1,680
Income before tax
-24,001
-8,163
-20,038
-8,987
-22,013
Income tax expense
1.456
0
0
0
-1,427
Income from continuing operations
-24,002
-8,163
-20,038
-8,987
-20,586
Net income
-24,002
-8,163
-20,038
-8,987
-20,586
Net income available to common shareholders
-24,002
-13,814
-20,038
-8,987
-20,586
Basic EPS
-6.21
-
-9.68
-8.25
-38.50
Diluted EPS
-6.21
-
-9.68
-8.25
-38.50
Basic average shares
2,100
-
2,070
1,089
534.068
Diluted average shares
2,100
-
2,070
1,089
534.068